Down-regulation of phospholipase D stimulates death of lung cancer cells involving up-regulation of the long ncRNA ANRIL

Anticancer Research

Volumn 35, Issue 5, 2015, Pages 2795-2803

  Kang, Yeon Ho ^a   Kim, Dongkyun ^a   Jin, Eun Jung ^a  

^a Wonkwang University   (South Korea)

Author keywords

ANRIL; H460 cells; LncRNA; Lung cancer; PLD inhibitor

Indexed keywords

LONG NON CODING RNA ANRIL; LONG UNTRANSLATED RNA; PHOSPHOLIPASE D; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; ANRIL LONG NON-CODING RNA, HUMAN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL TRANSFORMATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PHOSPHOLIPASE D; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 84929678484     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Liu Y, Li M, Zhang G and Pang Z: MicroRNA-10b overexpression promotes non-small cell lung cancer cell proliferation and invasion. Eur J Med Res 18(1): 41-48, 2013.
2. Willis BC, duBois, RM and Borok Z: Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 3(4): 377-382, 2006.
3. Su W, Chen Q and Frohman MA: Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol 5(9): 1477-1486, 2009.
4. Kang DW, Choi KY and Min do S: Phospholipase D meets Wnt signaling: a new target for cancer therapy. Cancer Res 71(2): 293-297, 2011.
5. Esteller M: Non-coding RNAs in human disease. Nat Rev Genet 12(12): 861-874, 2011.
6. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E and Olson EN: Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18(3): 282-293, 2010.
7. Acunzo M1, Romano G, Palmieri D, Laganá A, Garofalo M, Balatti V, Drusco A, Chiariello M, Nana-Sinkam P and Croce CM: Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2. Proc Natl Acad Sci USA 110(21): 8573-8578, 2013.
8. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST and Ghoshal K: Down-regulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99(3): 671-678, 2006.
9. Anand S1, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM and Cheresh DA: MicroRNA-132-mediated loss of p120RASGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 16(8): 909-914, 2010.
10. Fatica A and Bozzoni I: Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15(1): 7-21, 2014.
11. Spizzo R, Almeida MI, Colombatti A and Calin GA: Long noncoding RNAs and cancer: A new frontier of translational research? Oncogene 31(43): 4577-4587, 2012.
12. Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T and Calin GA: Long Noncoding RNA in Prostate, Bladder and Kidney Cancer. Eur Urol 65(6): 1140-1151, 2014.
13. Zhang Q, Su M, Lu G and Wang J: The complexity of bladder cancer: long noncoding RNAs are on the stage. Mol Cancer 12(1): 101-108, 2013.
14. Marks LS and Bostwick DG: Prostate cancer specificity of PCA3 gene testing: Examples from clinical practice. Rev Urol 10(3): 175-181, 2008.
15. Benetatos L, Vartholomatos G and Hatzimichael E: MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer 129(4): 773-779, 2011.
16. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y and Qiu F: Up-regulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst 8(9): 2289-2294, 2012.
17. Ono H1, Motoi N, Nagano H, Miyauchi E, Ushijima M, Matsuura M, Okumura S, Nishio M, Hirose T, Inase N and Ishikawa Y: Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness and clinical relapse in small-cell lung cancer. Cancer Med 3(3): 632-642, 2014.
18. Rubio-Somoza I, Weigel D, Franco-Zorilla JM, Garcia JA and Paz-Ares J: ceRNAs: miRNA target mimic mimics. Cell 147(7): 1431-1432, 2011.
19. Sun Y and Chen J: mTOR signaling: PLD takes center stage. Cell Cycle 7(20): 3118-3123, 2008.
20. Shi X1, Sun M, Liu H, Yao Y, Kong R, Chen F and Song Y: A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog DOI 10.1002/mc.22120, 2013.
21. Park JB1, Lee CS, Jang JH, Ghim J, Kim YJ, You S, Hwang D, Suh PG and Ryu SH: Phospholipase signalling networks in cancer. Nat Rev Cancer 12(11): 782-792, 2012.
22. Xu MD, Qi P and Du X: Long non-coding RNAs in colorectal cancer: implications for pathogenesis and clinical application. Mod Pathol 27(10): 1310-1320, 2014.
23. Wapinski O and Chang HY: Long noncoding RNAs and human disease. Trends Cell Biol 21(6): 354-361, 2011.
24. Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z and Sharpless NE: Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet 6(12): e1001233, 2010.
25. Folkersen L1, Kyriakou T, Goel A, Peden J, Mälarstig A, Paulsson-Berne G, Hamsten A, Hugh Watkins, Franco-Cereceda A, Gabrielsen A and Eriksson P: Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One 4(11): e7677, 2009.
26. Congrains A, Kamide K, Ohishi M and Rakugi H: ANRIL: Molecular Mechanisms and Implications in Human Health. Int J Mol Sci 14(1): 1278-1292, 2013.
27. Pasmant E, Laurendeau I, Héron D, Vidaud M, Vidaud D and Bièche I: Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 67(8): 3963-3969, 2007.
28. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J and Keavney B: Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet 6(4): e1000899, 2010.
29. Salzman J, Gawad C, Wang PL, Lacayo N and Brown PO: Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One 7(2): e30733, 2012.
30. Sato K, Nakagawa H, Tajima A, Yoshida K and Inoue I: ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1. Oncol Rep 24(3): 701-707, 2010.
31. Matheu A, Maraver A, Collado M, Garcia-Cao I, Cañamero M, Borras C, Flores JM, Klatt P, Viña J and Serrano M: Anti-aging activity of the Ink4/Arf locus. Aging Cell 8(2): 152-161, 2009.
32. Congrains A, Kamide K, Katsuya T, Yasuda O, Oguro R, Yamamoto K, Ohishi M and Rakugi H: CVD-associated noncoding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun 419(4): 612-616, 2012.